Elucid raises $80M in funding round

AI imaging software developer Elucid recently raised $80 million in series C funding, led by Elevage Medical Technologies, with additional participation from industry strategic and existing investors.

The company said this funding will help with the expansion of commercialization efforts to provide physicians and patients with critical information to combat heart disease. This round brings the company’s total funding to $121 million since inception.

Elucid’s software has 501(k) clearance by the U.S. Food and Drug Administration (FDA) and can characterize arterial plaque, simulating what pathologists would see under a microscope. The company is also pursuing an indication for non-invasive measurement of fractional flow reserve, derived from its PlaqueIQ technology, to measure coronary blockages and the extent of ischemia.

The company also announced that Kelly Huang, PhD, will join Elucid's board of directors.

More in Artificial Intelligence
Aidoc
142 W 57TH ST
New York, NY 10019
HeartLung AI
2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021
Heartlung Highres Png
Visage Imaging
12250 El Camino Real
12625 High Bluff Drive Suite 205 San Diego, CA, USA 92130
Visage Imaging Logo
MEDICAL IP
9F, Yeonkang Building, 15, Jong-ro-33-gil, Jongno-gu, Seoul, Republic of Korea
Medical Ip Ci
Radiology-Data (Dedomena Healthcare LLP)
5A Ratlam Kothi, Indore (India)
ScreenPoint Medical
Toernooiveld 300 6525 EC Nijmegen The Netherlands
Philips
3000 Minuteman Road
Andover, MA 01845
Philips Wordmark Ali Global
AIRS Medical Inc.
13,14F, Keungil Tower, 223, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea
Airs Medical
Voronoi Health Analytics Inc.
997 Seymour St #250, Vancouver, BC, Canada
RealTime Medical
7111 Syntex Dr, 3rd Floor Mississauga, ON, L5N 8C3
Realtime Med
PaxeraHealth
1280 Centre St.
85 Wells Ave, Suite 120 Newton, MA, USA 02459
PaxeraHealth Logo
Synapsica Healthcare
2591 Dallas Parkway Suite 300 Frisco TX, United States 75034
Page 1 of 4
Next Page